C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
260/242.4
C07D 473/04 (2006.01) C07D 473/06 (2006.01) C07D 473/08 (2006.01)
Patent
CA 1271473
8-ARYLXANTHINES Abstract of the Disclosure 1,3-alkylsubstituted-8-(3,4-,3- or 4-substituted phe- nyl)xanthines and pharmaceutically acceptable salts of such com- pounds are disclosed. The 3-substituents are hydrogen, dimethylaminomethyl, or 2,3-dihydroxypropyloxy. The 4- substituents are selected from hydroxy, cyano, -NHCON(R5)2, -C(=NH)N(R5)2, -NH-C(=NH)N(R5)2, with each R5 independently being hydrogen or an alkyl group of one to three carbons and provided that when the 3-substituent is hydrogen the 4-substituent is not hydroxy or hydrogen. The compounds are potent adenosine receptor antagonists having relatively low lipophilicity. The compounds are intended for use as bronchodilators and cardiotonics.
551660
Erickson Ronald H.
Hicks Rickey P.
Rzeszotarski Waclaw Janusz
Gowling Lafleur Henderson Llp
Marion Laboratories Inc.
LandOfFree
8-arylxanthines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-arylxanthines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-arylxanthines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1226637